BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the Biologics License Application (BLA) for the subcutaneous formulation ...
It is expected that Herjuema, Celltrion's anticancer drug, will be able to be administered as a subcutaneous (SC) injection in under five minutes. Celltrion said on Dec. 8 that it plans to submit ...
Both intravenous (IV) and intramuscular (IM) administration of the monoclonal antibody tixagevimab/cilgavimab rapidly eliminated culturable SARS-CoV-2, with both ...
The Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for Leqembi ® Iqlik ™, a once weekly lecanemab-irmb subcutaneous (SC) injection, for maintenance dosing to ...
It's a sad and inconvenient fact that many drugs have to be administered in the form of a slow intravenous (IV) drip, as opposed to a single quick injection. That may be about to change, however, ...
Attractive safety profile demonstrated across all dosing cohorts and routes of administration (IV, SC, and IM); all reported adverse events (AEs) deemed unrelated or classified as mild to moderate and ...
With Bristol Myers Squibb (BMS) now rolling out the SC version of rival nivolumab (Opdivo Qvantig), the shift from 30-minute intravenous (IV) infusion to 5-minute SC injection could be one of the most ...
A federal judge declined to stop Stephen Stanko’s execution, scheduled for Friday evening. The judge limited arguments to lethal injection, the method Stanko chose over firing squad. Stanko’s lawyers ...
CHARLESTON, S.C. (AP) — A federal judge Wednesday told lawyers for a South Carolina inmate scheduled to die in two days that he doesn’t plan to stop the execution because they didn’t have evidence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback